From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Pathogens

Persons Infected with Novel Coronavirus May be ‘Symptom-Free’ for 5 Days

Pooled analysis of confirmed cases used to estimate length of incubation period of COVID-19

by Global Biodefense Staff
March 9, 2020
We Must Protect the Frontline Warriors Against COVID-19 by Ensuring Health Care Workers Have Necessary PPE

This scanning electron microscope image shows SARS-CoV-2 —previously known as 2019-nCoV, the virus that causes COVID-19. Credit: NIAID-RML

Research published this week in the Annals of Internal Medicine suggests that persons infected with SARS-CoV-2, the newly-identified virus that causes coronavirus disease COVID-19, may be symptom-free for about 5 days on average, and should expect to experience symptoms within 12 days.

The findings support current recommendations by the US Centers for Disease Control and Prevention (CDC) to actively monitor patients for 14 days after an assumed exposure to SARS-CoV-2 and have important implications for informing control activities.

Researchers from Johns Hopkins Bloomberg School of Public Health conducted an analysis of news reports, public health reports, and press releases from 50 provinces, regions, and countries outside of Wuhan, China to estimate the length of the incubation period of COVID-19, the time from exposure to symptom onset. They found information on 181 confirmed cases with identifiable exposure and symptom onset windows.

Based on the available data, the researchers estimated the median incubation period of COVID-19 to be 5.1 days and 97.5 percent of those who develop symptoms appeared to do so within 11.5 days of infection. These estimates imply that, under conservative assumptions, 101 out of every 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine, which supports current CDC recommendations.

The authors caution that given recent evidence of SARS-CoV-2 transmission by mildly symptomatic and asymptomatic individuals, time from exposure to onset of infectiousness (latent period) may be shorter than the estimated incubation period, with important implications for transmission dynamics.


This information is not intended as medical advice or clinician guidance. This content contains edited excerpts to bring attention to the work of the researchers and study authors. Please support their efforts and click through for the full context.

From Our Partners
Tags: CoronavirusCOVID-19Editor PickMagazine Edition 11 March 2020SARS-CoV-2

Related Posts

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses
Pathogens

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

April 11, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC